SCHEMBL7133809

SCHEMBL7133809

O=C1Nc2ccc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)cc2C1=Cc1ccnc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOGAT2 Q3SYC2 4/20 0.50
MGAT2 Q10469 3/20 0.47
TLK2 Q86UE8 3/20 0.44
NTRK1 P04629 2/20 0.42
SYK P43405 2/20 0.42
PRKDC P78527 1/20 0.41
CLK1 P49759 1/20 0.41
FCER2 P06734 1/20 0.41
NTRK3 Q16288 1/20 0.41
NTRK2 Q16620 1/20 0.41
AR P10275 1/20 0.39
HSPD1 P10809 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN5 P54829 1/20 0.39
HSPE1 P61604 1/20 0.39
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
MAP2K4 P45985 1/20 0.39
IDH2 P48735 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360936 0.83 MOGAT2 (0.54) MOGAT2MGAT2TLK2PRKDCAR
SCHEMBL7137514 0.83 SYK (0.52) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL5358796 0.83 NTRK1 (0.65) MOGAT2MGAT2NTRK1SYKPRKDC
SCHEMBL5362504 0.82 MOGAT2 (0.49) MOGAT2MGAT2TLK2NTRK1SYK
SCHEMBL7131379 0.82 MOGAT2 (0.57) MOGAT2MGAT2NTRK1SYKPRKDC
SCHEMBL5366412 0.82 MOGAT2 (0.55) MOGAT2MGAT2TLK2NTRK1SYK
SCHEMBL5361507 0.82 MOGAT2 (0.55) MOGAT2MGAT2TLK2NTRK1SYK
SCHEMBL5357745 0.82 MOGAT2 (0.58) MOGAT2MGAT2PRKDCARPKM
SCHEMBL7138189 0.81 MOGAT2 (0.50) MOGAT2MGAT2TLK2PRKDCAR
SCHEMBL7132931 0.81 MOGAT2 (0.52) MOGAT2MGAT2TLK2PRKDCAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed